BUP One Step Buprenorphine Rapid Test (Oral Fluid)
Rapid lateral flow immunoassay for the qualitative detection of buprenorphine in oral fluid, used by healthcare professionals to screen for recent opioid exposure. CE Marked.
Product Description
This qualitative test is based on competitive binding in a lateral flow device. A solid-phase membrane carries buprenorphine antibody and the matching drug-protein conjugate, with the antibody coupled to colloidal gold. Applied oral fluid migrates by capillary action and any buprenorphine present competes with the conjugate for limited antibody binding sites. When enough drug is present it saturates the antibody, the conjugate is not captured at the test line, and the test line disappears — a missing test line is read as positive. In a negative sample a visible test line forms. A colored control line must appear in every valid run, confirming adequate specimen and proper membrane wicking.
Buprenorphine is a potent analgesic prescribed for opioid dependence and used as substitution therapy. It produces less physical dependence than methadone, but saliva levels after therapeutic dosing can be low while higher levels occur in misuse, so a positive result alone cannot distinguish prescribed therapy from non-prescribed use. Oral fluid testing indicates recent exposure, but interpretation should consider legitimate medication and clinical history. The test is a preliminary qualitative screen only; it does not measure concentration, timing or impairment. Presumptive positives require laboratory confirmation, and a physician should make the final diagnosis.
Cut-off Levels
| Product Name | Cat. No. | Specimen | Cut-off | Format |
|---|---|---|---|---|
| BUP Buprenorphine | BUP-R02 | Oral Fluid | 10ng/ml | Device |
Send an Inquiry
Tell us the product and quantity you need. We will reply by email with pricing, packaging and availability for the BUP One Step Buprenorphine Rapid Test (Oral Fluid).